When will the takeover happen?

Discussion in 'GlaxoSmithKline' started by anonymous, Sep 4, 2015 at 6:33 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    I hope you're right and that GSK touches $56/share again.
     

  2. anonymous

    anonymous Guest

    If you mean stuck with worthless declining stock that is supposed to be part of the compensation package, then by all means 'buy'.
     
  3. anonymous

    anonymous Guest

    look at stock history
     
  4. anonymous

    anonymous Guest

    same as I retired years ago !
     
  5. anonymous

    anonymous Guest

    Several investment bankers have upgraded GSK based on promise of pipeline. Way to go Moncef and Patrick!!!
     
  6. anonymous

    anonymous Guest

    Smoke & mirrors
     
  7. anonymous

    anonymous Guest

    Agreed. All that means is JP Morgan has idiots for analysts
     
  8. anonymous

    anonymous Guest


    We are so lucky to have you as our resident expert so that you can help everyone identify idiots.
     
  9. anonymous

    anonymous Guest

    Moncef, c'est vous? Mangez la merde
     
  10. anonymous

    anonymous Guest

    Speaking of idiots, here is the king of idiots, also known as the board troll.
     
  11. anonymous

    anonymous Guest

    Not an idiot, but a mentally ill child.
     
  12. anonymous

    anonymous Guest

    Probably both.
     
  13. anonymous

    anonymous Guest

    OK children, let's keep this at an adult level. Word on Wall Street is that they are anticipating GSK to show 8% increase over 3Q earnings from last year. That should push the stock into the mid-forties and if there is a strong presentation for R&D day, we may touch $50 again.

    Halle"freakin"lulah
     
  14. anonymous

    anonymous Guest

    Yes this could happen although I see a high of no more than 45 but I will take that
     
  15. anonymous

    anonymous Guest

    Funny now how all the banks are playing "Follow the Leader" and upgrading their recommendation on GSK. Could a "Buy" rating be coming soon? Word on the street is that GSK will come in with robust earnings. This should squelch any takeover rumors.
     
  16. anonymous

    anonymous Guest

    GSK to buy Valeant?
     
  17. anonymous

    anonymous Guest

    Hahahahhahahahhahahaha !
     
  18. anonymous

    anonymous Guest

    GSK $65/share by end of year. Watch and see. Surprise announcement coming next week.
     
  19. anonymous

    anonymous Guest

    Yeah. Right. BS
     
  20. anonymous

    anonymous Guest

    PWI! No more "posting while intoxicated."